Answer
Zolgensma (onasemnogene abeparvovec) is administered as a single-dose intravenous infusion using a syringe pump over approximately 60 minutes, not as an intravenous push or bolus.
Sources for this answer
- Zolgensma 2 x 10Exp13 vector genomes/mL solution for infusionNovartis Pharmaceuticals UK Ltd · emc · SmPC §4.2 Posology and method of administration · Version 16Document updated
Sources checked